Stay updated on DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Sign up to get notified when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.

Latest updates to the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page header, which is a minor metadata update with no impact on core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoChange DetectedMinor metadata updates were made to the page, including the addition of related topics (MedlinePlus Genetics), a new study revision label (v3.3.1), and the removal of revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check24 days agoChange DetectedA government funding/operating-status notice was removed from the page; this does not affect the study details, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check31 days agoChange DetectedRemoved 'Type 2 diabetes' and the related topic 'MedlinePlus Genetics' from the page's keywords/MeSH terms.SummaryDifference0.1%

- Check38 days agoChange DetectedNo additions or deletions detected between the old and new screenshots of the study page.SummaryDifference0.2%

- Check52 days agoChange Detected- Removed a MedlinePlus Genetics related topic: Type 2 diabetes, reducing the list of genetic topics covered on the page. This is a high-importance change as it eliminates a core health topic.SummaryDifference0.2%

Stay in the know with updates to DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Enter your email address, and we'll notify you when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.